Inventor

ERION MARK D

US54 patents

⚠️ This page may combine multiple inventors who share the name “ERION MARK D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ERION MARK D

METABASIS THERAPEUTICS INC

Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphatase

Prodrugs for liver specific drug delivery

Benzimidazole inhibitors of fructose 1,6-bisphosphatase

Prodrugs phosphorus-containing compounds

Purine inhibitors of fructose 1,6-bisphosphatase

Indole and azaindole inhibitors of fructose-1,6-bisphosphatase

Benzimidazole inhibitors of fructose 1,6-bisphosphatase

Water soluble adenosine kinase inhibitors

C-4&#39; modified adenosine kinase inhibitors

Orally active adenosine kinase inhibitors

Prodrugs for phosphorus-containing compounds

Indole and azaindole inhibitors of Fructose-1,6-biphosphatase

Phosphorus-containing thyromimetics

Cytarabine monophosphate prodrugs

Phosphorus-containing thyromimetics

Phosphorus-containing prodrugs

Cytarabine monophosphate prodrugs

Purine inhibitors of fructose-1,6-bisphosphatase

Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes

Adenosine kinase inhibitors

Phosphorus-containing prodrugs

2′-C-methyl nucleoside derivatives

Prodrugs for liver specific drug delivery

Heteroaromatic inhibitors of fructose 1,6-bisphosphatase

Phosphonic acid based prodrugs of PMEA and its analogues

Prodrugs for phosphorus-containing compounds

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

Thyromimetics for the treatment of fatty liver diseases

Purine inhibitors of fructose-1,6-bisphosphatase

GENSIA INC

C-4&#39; modified adenosine kinase inhibitors

Lyxofuranosyl analogues of adenosine

Methods for treating adenosine kinase related conditions

Water soluble adenosine kinase inhibitors

Orally active adenosine kinase inhibitors

Method and compounds for diagnosing coronary artery disease

BIOCRYST INC

7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and pharmaceutical uses and compositions containing the same

2-amino-7-(heterocyclomethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same

2-amino-7-(alicyclomethyl)-3H,5H,-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same

2-amino-7-(pyridinylmethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same

7-substituted derivatives of 2-amino-3H,5H-pyrrolo(3,2-d)pyrimidin-4-ones and pharamceutical uses and compositions containing the same

CIBA GEIGY CORP

Phosphono/biaryl substituted dipetide derivatives

Phosphono/biaryl substituted dipeptide derivatives

ERION MARK D

Phosphorus-containing prodrugs

Phosphorus-containing prodrugs

GENSIA SICOR INC

Inhibitors of adenosine monophosphate deaminase

REDDY K RAJA

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

CABLE EDWARD E

Thyromimetics for the treatment of fatty liver diseases

TIAN FENG

Activators of glucokinase

BIOCRYST PHARM INC

9-subtituted-8-unsubstituted-9-deazaguanines

C-4' modified adenosine kinase inhibitors

C-4' modified adenosine kinase inhibitors